Clear All
12482 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
67046-1242-03 67046-1242 Ondansetron Hydrochloride Ondansetron Hydrochloride 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Jun 16, 2026 In Use
60505-6411-00 60505-6411 Hydrocortisone sodium succinate Hydrocortisone sodium succinate 100.0 mg/2mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous Jun 19, 2026 In Use
71390-0250-02 71390-0250 Pemetrexed Pemfexy 25.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Jun 22, 2026 In Use
83831-0145-25 83831-0145 Etoposide Avopef 500.0 mg/25mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Jun 24, 2026 In Use
00121-1100-04 00121-1100 PrednisoLONE Sodium Phosphate PrednisoLONE Sodium Phosphate 5.0 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jun 26, 2026 In Use
69448-0008-63 69448-0008 Filgrastim-laha FILKRI 300.0 ug/.5mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous Jun 29, 2026 In Use
70518-4685-00 70518-4685 Ondansetron Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Jun 29, 2026 In Use
87441-0064-01 87441-0064 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Jun 30, 2026 In Use
60505-6423-00 60505-6423 Trabectedin EVDI 0.05 mg/mL Chemotherapy Alkylating Agent Natural Product Intravenous Jun 30, 2026 In Use
70709-0192-12 70709-0192 Nilotinib CAVHANZA 80.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jun 30, 2026 In Use
70709-0191-12 70709-0191 Nilotinib CAVHANZA 60.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jun 30, 2026 In Use
80005-0139-10 80005-0139 Letrozole Letrozole 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral Jun 30, 2026 In Use
80005-0139-08 80005-0139 Letrozole Letrozole 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral Jun 30, 2026 In Use
42023-0259-00 42023-0259 LEUPROLIDE ACETATE LEUPROLIDE ACETATE 1.0 mg/.2mL Hormonal Therapy GnRH Agonist Subcutaneous Jun 30, 2026 In Use
83831-0159-02 83831-0159 Fulvestrant CLIGAVYX 250.0 mg/5mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular Jul 1, 2026 In Use
82249-0020-90 82249-0020 IMATINIB MESYLATE IMATINIB MESYLATE 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jul 3, 2026 In Use
69448-0021-63 69448-0021 Denosumab-desu OSVYRTI 60.0 mg/mL Immunotherapy Monoclonal Antibody RANKL Subcutaneous Jul 6, 2026 In Use
70404-0077-16 70404-0077 Prednisolone oral Prednisolone 15.0 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jul 8, 2026 In Use
70404-0077-14 70404-0077 Prednisolone oral Prednisolone 15.0 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jul 8, 2026 In Use
87441-0088-01 87441-0088 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Jul 8, 2026 In Use
00024-0674-01 00024-0674 Isatuximab-irfc Sarclisa Escena 140.0 mg/mL Immunotherapy Monoclonal Antibody CD38 Subcutaneous Jul 9, 2026 In Use
72579-0125-00 72579-0125 Tislelizumab-jsgr TEVIMBRA 10.0 mg/mL Immunotherapy Checkpoint Inhibitor PD-1 Intravenous Jul 13, 2026 In Use
69448-0022-63 69448-0022 Denosumab-desu JUBEREQ 70.0 mg/mL Immunotherapy Monoclonal Antibody RANKL Subcutaneous Jul 13, 2026 In Use
84577-0751-01 84577-0751 Gedatolisib REVTORPYK 180.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR, PI3K (⍺,β,ƍ,γ) Intravenous Jul 14, 2026 In Use
69448-0009-63 69448-0009 Filgrastim-laha FILKRI 480.0 ug/.8mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous Jul 15, 2026 In Use

Found 12482 results — Export these results